Economic Burden Associated with Extrapyramidal Symptoms in a Medicaid Population with Schizophrenia

No studies have assessed the economic impact of extrapyramidal symptoms due to atypical antipsychotics in schizophrenia. To assess healthcare resource use and medical costs associated with extrapyramidal symptoms in patients with schizophrenia. A retrospective analysis of Marketscan(®) Medicaid Mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Abouzaid, Safiya, Tian, Haijun, Zhou, Huanxue, Kahler, Kristijan H., Harris, Michelle, Kim, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895443/
https://www.ncbi.nlm.nih.gov/pubmed/23229052
http://dx.doi.org/10.1007/s10597-012-9561-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895443/
https://www.ncbi.nlm.nih.gov/pubmed/23229052
http://dx.doi.org/10.1007/s10597-012-9561-7

Ejemplares similares